Colorado Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 18 (95% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 13,108
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 67.71%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 4,911
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 72.03%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 25.30% 22.74%
White, Hispanic/Latino Patients 29.49% 32.29%
Black/African American, Non-Hispanic/Latino Patients 6.14% 7.47%
Black/African American, Hispanic/Latino Patients 0.37% 0.33%
Asian Patients3 1.86% 2.69%
American Indian/Alaska Native Patients3 0.94% 0.90%
Native Hawaiian/Other Pacific Islander Patients3 0.27% 0.35%
Patients with More Than One Race3 1.14% 1.10%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 12.84% 13.46%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 4.20% 3.69%
Unreported/Refused to Report Race and Ethnicity 17.45% 14.99%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 5,949
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 80.97%
COVID-19 Immunization Series Completed 3,822
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 83.69%
COVID-19 Immunization Series Additional 6,616
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 77.77%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 16.69% 14.10% 18.77%
White, Hispanic/Latino Patients 40.78% 41.18% 38.30%
Black/African American, Non-Hispanic/Latino Patients 9.11% 8.27% 5.46%
Black/African American, Hispanic/Latino Patients 0.35% 0.52% 0.17%
Asian Patients3 1.45% 2.88% 2.55%
American Indian/Alaska Native Patients3 0.96% 1.18% 0.86%
Native Hawaiian/Other Pacific Islander Patients3 0.40% 0.39% 0.15%
Patients with More Than One Race3 1.08% 1.10% 1.10%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 16.88% 16.82% 17.09%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.17% 2.20% 1.63%
Unreported/Refused to Report Race and Ethnicity 10.14% 11.36% 13.91%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 22.22%
1 to 24 Hours 22.22%
More Than 24 Hours 55.56%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 16.67%
Staffing to administer the vaccine 55.56%
Vaccine confidence 22.22%
Vaccine storage capacity 11.11%
Vaccine supply 0.00%
Other 0.00%
None 27.78%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 0.00%
Average Percent of Health Center Visits Conducted Virtually 15.83%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 33.33%
Number of Mobile Van Sites 14
Number of Pop-up Clinics 2
Number of School-Based Vaccination Sites 11
Number of Family Vaccination Clinics 72

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 11.11%
Refer patients to another organization that provides monoclonal antibody therapies 66.67%
None 27.78%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 5.56%
Patient awareness/education 5.56%
Staffing capacity 11.11%
Therapy administration/onsite logistics 0.00%
Other 5.56%
None 72.22%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 4
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 21,030

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 100.00%
Provide to General Public Who Came to the Health Center 25.00%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 0.00%
Provide at Other Community Events 0.00%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 25.00%
Other 0.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 1
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 46.15%

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 30.77%
White, Hispanic/Latino Patients 38.46%
Black/African American, Non-Hispanic/Latino Patients 0.00%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 0.00%
American Indian/Alaska Native Patients3 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 7.69%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Unreported/Refused to Report Race and Ethnicity 7.69%

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers 0.00%
Patients Experiencing Homelessness 0.00%
Patients Who Are Residents of Public Housing 0.00%
Patients with Limited English Proficiency 23.08%
Children Under 18 Years of Age 0.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022